Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OptimizeRx CorpOPRX · Entity 213 | PRESIDENT AND CSO | December 02, 2021 | December 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OptimizeRx Corp
Report date December 02, 2021 · Filed December 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Pursuant to 10B5-1 PlanSEC Table I · non-derivative | Direct | 71,049 |
Reported balance
After 2021-12-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-12-02 · Sale · Disposed 3,558 · Balance 71,049 F1: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 74,607 |
Reported balance
After 2021-12-02 transaction · row 2
1 source rowRow 2 · 2021-12-02 · Exercise / conversion · Acquired 3,558 · Balance 74,607 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.51 · Expires 2025-03-11 | Direct | 90,760 |
Reported balance
After 2021-12-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-02 · Exercise / conversion · Disposed 3,558 · Balance 90,760 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2021 Filed Dec 3, 2021 21:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 3,558 | $7.51 Strike: $7.51 | $26,720.58 |
DisclosureSEC source: 0001213900-21-063363 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,760 Underlying: Common Stock · 3,558 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 21:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 3,558 | $7.51 | $26,720.58 |
DisclosureSEC source: 0001213900-21-063363 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 21:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock Pursuant to 10B5-1 Plan | 3,558 | $61.48 | $218,745.84 |
DisclosureSEC source: 0001213900-21-063363 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,049 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-056471 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRES. & CHIEF STRATEGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,318 Underlying: Common Stock · 15,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock Pursuant to 10B5-1 Plan | 15,000 | $95.45 | $1,431,750.00 |
DisclosureSEC source: 0001213900-21-056471 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRES. & CHIEF STRATEGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 15,000 | $7.51 | $112,650.00 |
DisclosureSEC source: 0001213900-21-056471 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRES. & CHIEF STRATEGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-051450 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,318 Underlying: Common Stock · 15,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock Pursuant to 10B5-1 Plan | 15,000 | $84.67 | $1,270,050.00 |
DisclosureSEC source: 0001213900-21-051450 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 15,000 | $7.51 | $112,650.00 |
DisclosureSEC source: 0001213900-21-051450 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-046665 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,318 Underlying: Common Stock · 15,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock Pursuant to 10B5-1 Plan | 15,000 | $68.39 | $1,025,850.00 |
DisclosureSEC source: 0001213900-21-046665 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 15,000 | $7.51 | $112,650.00 |
DisclosureSEC source: 0001213900-21-046665 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-040134 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,318 Underlying: Common Stock · 15,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock Pursuant to 10B5-1 Plan | 15,000 | $55.76 | $836,400.00 |
DisclosureSEC source: 0001213900-21-040134 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 15,000 | $7.51 | $112,650.00 |
DisclosureSEC source: 0001213900-21-040134 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:15 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 71,667 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001213900-21-037492 · ownership.xml · derivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,318 Underlying: Common Stock · 71,667 shares Expires 2022-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:15 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 67,195 | $3.15 | $211,664.25 |
DisclosureSEC source: 0001213900-21-037492 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This Form is being filed to report the exercise of a stock option for a total of 71,667 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 67,195 shares of common stock. Read SEC document |
| July 02, 2021 Filed Jul 2, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001213900-21-035593 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,985 Underlying: Common Stock · 15,000 shares Expires 2022-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 2, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock Pursuant to 10B5-1 Plan | 15,000 | $57.81 | $867,150.00 |
DisclosureSEC source: 0001213900-21-035593 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,412 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 02, 2021 Filed Jul 2, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 15,000 | $3.15 | $47,250.00 |
DisclosureSEC source: 0001213900-21-035593 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 13,333 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001213900-21-031476 · ownership.xml · derivative · entry 4 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,985 Underlying: Common Stock · 13,333 shares Expires 2022-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock Pursuant to 10B5-1 Plan | 13,333 | $50.85 | $677,983.05 |
DisclosureSEC source: 0001213900-21-031476 · ownership.xml · nonDerivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,412 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 13,333 | $3.15 | $41,998.95 |
DisclosureSEC source: 0001213900-21-031476 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock Pursuant to 10B5-1 Plan | 1,667 | $51.30 | $85,517.10 |
DisclosureSEC source: 0001213900-21-031476 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,412 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock | 15,000 | $42.95 | $644,250.00 |
DisclosureSEC source: 0001213900-21-027937 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,079 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 00:04 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantStock Option · Derivative | 24,093 | $0.00 Strike: $37.50 | $0.00 |
DisclosureSEC source: 0001213900-21-001539 · ownership.xml · derivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,318 Underlying: Common Stock · 24,093 shares Expires 2024-01-07 F1 · derivative.exercise_date: The Stock Option will vest 1/3 at the end of each anniversary from issuance. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 21:20 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantStock Option · Derivative | 63,558 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-20-006356 · ownership.xml · derivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,225 Underlying: Common Stock · 63,558 shares Expires 2025-03-11 F1 · derivative.exercise_date: The Stock Option will vest 25% at the end of each quarter starting on 3/31/2020. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 20:15 UTC | OptimizeRx Corp OPRX · Entity 213 | ConversionContingent Stock Grant · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-19-005237 · ownership.xml · derivative · entry 2 Paramore Miriam J · CIK 0001713156 · RESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year. F1 · price: The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year. F1 · derivative.exercise_date: The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year. F2 · derivative.expiration_date: Not applicable Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 20:15 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-19-005237 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · RESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,079 F1 · price: The reporting person received a contingent stock grant subject to achievement of the Issuer's 2018 year-end revenue performance goals that were achieved for the year. Read SEC document |
| February 25, 2019 Filed Feb 26, 2019 22:20 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantRestricted Stock Grant · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-003166 · ownership.xml · derivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,667 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock grant represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The reporting person received a restricted stock grant that may vest on February 1, 2020, subject to achievement of the Issuer's year-end revenue performance goals. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 13:31 UTC | OptimizeRx Corp OPRX · Entity 213 | PurchaseCommon Stock | 1,015 | $9.85 | $9,997.75 |
DisclosureSEC source: 0001213900-18-017586 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,412 Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 20:15 UTC | OptimizeRx Corp OPRX · Entity 213 | PurchaseCommon Stock | 100 | $10.50 | $1,050.00 |
DisclosureSEC source: 0001213900-18-008259 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,397 Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:21 UTC | OptimizeRx Corp OPRX · Entity 213 | PurchaseCommon Stock | 1,600 | $8.11 | $12,976.00 |
DisclosureSEC source: 0001213900-18-007817 · f4061518paramore_optimize.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,897 Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:21 UTC | OptimizeRx Corp OPRX · Entity 213 | PurchaseCommon Stock | 3,400 | $8.05 | $27,370.00 |
DisclosureSEC source: 0001213900-18-007817 · f4061518paramore_optimize.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,297 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:15 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantRestricted Stock Grant · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-18-001236 · f4020118paramore_optimizerx.xml · derivative · entry 1 Paramore Miriam J · CIK 0001713156 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock grant represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The reporting person received a restricted stock grant that may vest on either February 1, 2019 or February 1, 2020, subject to achievement of the Issuer's year-end revenue performance goals. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| September 25, 2017 Filed Oct 6, 2017 12:30 UTC | OptimizeRx Corp OPRX · Entity 213 | PurchaseCommon Stock | 8,690 | $1.21 | $10,528.80 |
DisclosureSEC source: 0001213900-17-010341 · f4092517paramore_optimizerx.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,690 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.